120 related articles for article (PubMed ID: 17901412)
1. Inhibition of nuclear factor-kappaB in T cells suppresses lung fibrosis.
Fujimoto H; D'Alessandro-Gabazza CN; Palanki MS; Erdman PE; Takagi T; Gabazza EC; Bruno NE; Yano Y; Hayashi T; Tamaki S; Sumida Y; Adachi Y; Suzuki K; Taguchi O
Am J Respir Crit Care Med; 2007 Dec; 176(12):1251-60. PubMed ID: 17901412
[TBL] [Abstract][Full Text] [Related]
2. The effect of a T cell-specific NF-kappa B inhibitor on in vitro cytokine production and collagen-induced arthritis.
Gerlag DM; Ransone L; Tak PP; Han Z; Palanki M; Barbosa MS; Boyle D; Manning AM; Firestein GS
J Immunol; 2000 Aug; 165(3):1652-8. PubMed ID: 10903776
[TBL] [Abstract][Full Text] [Related]
3. A novel transcription factor inhibitor, SP100030, inhibits cytokine gene expression, but not airway eosinophilia or hyperresponsiveness in sensitized and allergen-exposed rat.
Huang TJ; Adcock IM; Chung KF
Br J Pharmacol; 2001 Nov; 134(5):1029-36. PubMed ID: 11682451
[TBL] [Abstract][Full Text] [Related]
4. The AP-1/NF-kappaB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia.
Moore-Carrasco R; Busquets S; Almendro V; Palanki M; López-Soriano FJ; Argilés JM
Int J Oncol; 2007 May; 30(5):1239-45. PubMed ID: 17390027
[TBL] [Abstract][Full Text] [Related]
5. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
[TBL] [Abstract][Full Text] [Related]
6. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852
[TBL] [Abstract][Full Text] [Related]
7. Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice.
Zhu T; Zhang W; Xiao M; Chen H; Jin H
Int J Mol Sci; 2013 Dec; 14(12):23581-96. PubMed ID: 24300094
[TBL] [Abstract][Full Text] [Related]
8. Differential cytokine regulation by NF-kappaB and AP-1 in Jurkat T-cells.
Khalaf H; Jass J; Olsson PE
BMC Immunol; 2010 May; 11():26. PubMed ID: 20507572
[TBL] [Abstract][Full Text] [Related]
9. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice.
Gurujeyalakshmi G; Wang Y; Giri SN
J Pharmacol Exp Ther; 2000 Apr; 293(1):82-90. PubMed ID: 10734156
[TBL] [Abstract][Full Text] [Related]
10. Thiol dependent NF-κB suppression and inhibition of T-cell mediated adaptive immune responses by a naturally occurring steroidal lactone Withaferin A.
Gambhir L; Checker R; Sharma D; Thoh M; Patil A; Degani M; Gota V; Sandur SK
Toxicol Appl Pharmacol; 2015 Dec; 289(2):297-312. PubMed ID: 26408225
[TBL] [Abstract][Full Text] [Related]
11. Dimethylfumarate inhibits nuclear binding of nuclear factor kappaB but not of nuclear factor of activated T cells and CCAAT/enhancer binding protein beta in activated human T cells.
Gerdes S; Shakery K; Mrowietz U
Br J Dermatol; 2007 May; 156(5):838-42. PubMed ID: 17381463
[TBL] [Abstract][Full Text] [Related]
12. A novel IkappaB kinase-beta inhibitor ameliorates bleomycin-induced pulmonary fibrosis in mice.
Inayama M; Nishioka Y; Azuma M; Muto S; Aono Y; Makino H; Tani K; Uehara H; Izumi K; Itai A; Sone S
Am J Respir Crit Care Med; 2006 May; 173(9):1016-22. PubMed ID: 16456147
[TBL] [Abstract][Full Text] [Related]
13. Sinapic acid ameliorates bleomycin-induced lung fibrosis in rats.
Raish M; Ahmad A; Ahmad Ansari M; Ahad A; Al-Jenoobi FI; Al-Mohizea AM; Khan A; Ali N
Biomed Pharmacother; 2018 Dec; 108():224-231. PubMed ID: 30219680
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive activity of endovanilloids: N-arachidonoyl-dopamine inhibits activation of the NF-kappa B, NFAT, and activator protein 1 signaling pathways.
Sancho R; Macho A; de La Vega L; Calzado MA; Fiebich BL; Appendino G; Muñoz E
J Immunol; 2004 Feb; 172(4):2341-51. PubMed ID: 14764703
[TBL] [Abstract][Full Text] [Related]
15. Both AP-1 and NF-kappaB seem to be involved in tumour growth in an experimental rat hepatoma.
Moore-Carrasco R; Busquets S; Figueras M; Palanki M; López-Soriano FJ; Argilés JM
Anticancer Res; 2009 Apr; 29(4):1315-7. PubMed ID: 19414381
[TBL] [Abstract][Full Text] [Related]
16. [The Study of the Effect and Mechanism of Glucagon Like Peptide-1 in Bleomycin-induced Pulmonary Fibrosis in Mice].
Liu M; Gou S; Chen HT; Chen ZH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 48(4):509-514. PubMed ID: 28752966
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic study of saikosaponin-d (Ssd) on suppression of murine T lymphocyte activation.
Wong VK; Zhou H; Cheung SS; Li T; Liu L
J Cell Biochem; 2009 May; 107(2):303-15. PubMed ID: 19301261
[TBL] [Abstract][Full Text] [Related]
18. Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Inhibitor as a Novel Therapeutic Tool for Lung Injury.
Fusco R; Siracusa R; D'Amico R; Cordaro M; Genovese T; Gugliandolo E; Peritore AF; Crupi R; Di Paola R; Cuzzocrea S; Impellizzeri D
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092214
[TBL] [Abstract][Full Text] [Related]
19. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation.
Saadane A; Soltys J; Berger M
J Allergy Clin Immunol; 2006 May; 117(5):1163-9. PubMed ID: 16675347
[TBL] [Abstract][Full Text] [Related]
20. Isotetrandrine protects against lipopolysaccharide-induced acute lung injury by suppression of mitogen-activated protein kinase and nuclear factor-kappa B.
Liang XM; Guo GF; Huang XH; Duan WL; Zeng ZL
J Surg Res; 2014 Apr; 187(2):596-604. PubMed ID: 24331940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
